Damage to vascular endothelium in the treatment of acute leukemia: in vitro study


Cite item

Full Text

Abstract

Aim. Cytostatic drugs used in the treatment of hemopoietic malignancies affect cells of other organs and systems, vascular endothelium, in particular. This leads to cardiovascular complications. We studied effects of some drugs and their combinations on cultured human endothelial cells (EC). Material and methods. Primary culture of umbilical human vein EC was used in the study. Cytosinearabinoside (cytozar, alexan, cytarabin) and daunorubicin were added in concentration from 1 ng/ml to 1 mg/ml; the action of the drugs was assessed by morphology of the cells, their viability, inclusion of bromodesoxyuridine by means of cloning, immunohistochemistry and flow cytofluorimetry. Results. It is shown that in a wide range of concentrations cytosinearabinoside and daunorubicine cause specific structural-functional changes in the cells related to cytostatic and cytotoxic effects.
Conclusion. The data of the study confirm that cardiovascular complications in the course of acute leukemia treatment are resultant from systemic damage to vascular endothelium.

References

  1. Charbord P. The microenvironmental cell population esential for the support of hematopoietic stem cells. In: Zon L., ed. Developmental biology of hematopoiesis. Oxford: Oxford Univ. Press; 1999.
  2. Hirschi К. K., D'Amore P. A. Control of angiogenesis by pericyte: molecular mechanism and significance. EXS, 1997; 79: 419-428.
  3. Vanhoutte P. M., Mombouli J. V. Vascular endothelium: vasoactive mediators. Progr. Cardiovasc. Dis. 1996; 39: 229- 238.
  4. Worthylake R., Burridge K. Leukocyte transendothelial migration: orchestrating the underlying molecular machinery. Curr. Opin. Cell Biol. 2001; 13: 569-577.
  5. Whetton A. D., Graham G. J. Homing and mobilization in the stem cell niche. Trends Cell Biol. 1999; 9: 233-238.
  6. Folkman J. Tumor angiogenesis. In: Mendelsohn J. et al., eds. The molecular basis of cancer. Philadelphia: W. B. Saunders; 1995. 206-232.
  7. Folkman J. Fighting cancer by attacking its blood supply. Sci. Am. 1996; 275: 150-154.
  8. Kini A. R., Peterson L. C., Tollman M. S., Lingen M. W. Angiogenesis in acute promyelocyte leukemia: induction by vascular endothelial growth factor and inhibition by all-trans-retinoic acid. Blood 2001; 97: 3919-3924.
  9. Perez-Atayde A. R., Saltan S. E., Tedrow U. et al. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am. J. Pathol. 1997; 150: 815-821.
  10. Dilly S. A., Jagger С. J. Bone marrow stromal cell changes in hematological malignancies. J. Clin. Pathol. 1990; 43: 942946.
  11. Kini A. R., Kay N. E., Peterson L. С. Increased bone marrow angiogenesis in В cell chronic lymphocytic leukemia. Leukemia 2000; 14: 1414-1418.
  12. Aguayo A., Kantarjan H., Manshouri T. et al. Angiogenesis in acute and chronic leukemias and myelodyslastic syndromes. Blood 2000; 96: 2240-2245.
  13. Vacca A., Di Loreto M., Ribatti D. et al. Bone marrow of patients with active multiple myeloma: angiogenesis and plasma cell adhesion molecules LFA-1, VLA-4, LAM-1, and CD44. Am. J. Hematol. 1995; 50: 9-14.
  14. Rajkumar S. V., Mesa R. A., Tefferi A. A review of angiogenesis and antiangiogenic therapy in hematologic malignancies. J. Hematother. Stem Cell Res. 2002; 11: 33-47.
  15. Peters G. J., van der Wilt С. L., van Moorsel С. J. A. et al. Basis for effective combination cancer chemothrapy with antimetabolites. Pharmacol. Ther. 2000; 87: 227-253.
  16. Bishop J. F. The treatment of adult acute myeloid leukemia. Semin. Oncol. 1997; 24: 57-69.
  17. Bassenge E. Endothelial function in different organs. Progr. Cardiovasc. Dis. 1986; 39: 209-228.
  18. Pearson J. D. Normal endothelial cell functions. Lupus 2000; 9: 183-188.
  19. Krishnaswamy G., Kelley I., Yerra L. et al. Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. J. Interferon Cytokine Res. 1999; 19: 91-104.
  20. Schwartz S. M., Benditt E. P. Aortic endothelial cell replication: Effect of age and hypertension in the rat. Circ. Res. 197741: 248-255.
  21. Gimbrone M. A., Cotran R., Folkman J. Human vascular endothelial cells in culture. J. Cell Biol. 1974; 60: 673-684.
  22. Reidy M. A., Schwartx S. M. Endothelial injury and regeneration. Lab. Invest. 1983; 48: 25-34.
  23. Smirnov V. N., Repin V. S., Tkachuk V. A., Chazov E. I. Vascular endothelium in atherosclerosis a multidisciplinary approach. In: Ryan U. S. Endothelial cells. Boca Raton, Florida' CRC Press; 1988; vol. 3: 139-215.
  24. Rafii S. Circulating endothelial precursors: mistery, reality, and promise. J. Clin. Invest. 2000; 105: 17-19.
  25. Lin Y., Weisdorf D. J., Solovey A., Hebbel R. P. Origin of circulating endothelial cells and endothelial outgrowth from blood. J. Clin. Invest. 2000; 105: 71-77.
  26. Kalivendi S. V., Kotamraju S., Zhao H. et al. Doxorubicin-induced apoptosis is associated with increased transcription of endothelial nitric-oxide synthase. J. Biol. Chem. 2001; 27647266-47276.
  27. Singal P. K., Ilskovic N. Doxorubicin-induced cardiomyopathy. N. Engl. J. Med. 1998; 339: 900-905.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2004 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies